Correlation Between Capri Holdings and Xbrane Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capri Holdings and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capri Holdings and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capri Holdings and Xbrane Biopharma AB, you can compare the effects of market volatilities on Capri Holdings and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capri Holdings with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capri Holdings and Xbrane Biopharma.

Diversification Opportunities for Capri Holdings and Xbrane Biopharma

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Capri and Xbrane is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Capri Holdings and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Capri Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capri Holdings are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Capri Holdings i.e., Capri Holdings and Xbrane Biopharma go up and down completely randomly.

Pair Corralation between Capri Holdings and Xbrane Biopharma

Given the investment horizon of 90 days Capri Holdings is expected to under-perform the Xbrane Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Capri Holdings is 4.89 times less risky than Xbrane Biopharma. The stock trades about -0.06 of its potential returns per unit of risk. The Xbrane Biopharma AB is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2,595  in Xbrane Biopharma AB on September 1, 2024 and sell it today you would lose (2,576) from holding Xbrane Biopharma AB or give up 99.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.9%
ValuesDaily Returns

Capri Holdings  vs.  Xbrane Biopharma AB

 Performance 
       Timeline  
Capri Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capri Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Xbrane Biopharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Capri Holdings and Xbrane Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capri Holdings and Xbrane Biopharma

The main advantage of trading using opposite Capri Holdings and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capri Holdings position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.
The idea behind Capri Holdings and Xbrane Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities